Venetoclax + Azacitidine vs. Induction Chemotherapy in AML

Clinical trial NCT04801797 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04801797
Sponsor: Massachusetts General Hospital
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia

Start date: 2021-05-20
Primary completion: 2027-01-01
Enrollment: 172

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.